Anti-Vimentin [J144]
Invented by Dr JOHN KEMSHEAD from SHIRE PHARMACEUTICALS
Invented at Institute Of Child Health
- Datasheet
- References (6)
- Inventor Info
Info
| Catalogue Number | 151112 |
| Applications | IHC IF IP WB |
| Antigen/Gene or Protein Targets | Vimentin |
| Reactivity | Human |
| Relevance | Vimentin is an intermediate filament protein, which is expressed in most cells of mesodermal origin but not epithelial cells. J144 may be used in the staining of intracellular proteins to determine tissue of origin. |
| Host | Mouse |
| Immunogen | Human rhabdosarcoma cell line JR1 |
| Subclass | IgM |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction, Developmental Biology, Neurobiology |
References: 6 entries
Doldo et al. 2015. Genes Cancer. 6(11-12):490-502. PMID: 26807202.
IHC
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis.
Europe PMC ID: 26807202
Dubicke et al. 2008. Mol Hum Reprod. 14(11):641-7. PMID: 18922847.
IF
Different secretion patterns of matrix metalloproteinases and IL-8 and effect of corticotropin-releasing hormone in preterm and term cervical fibroblasts.
Europe PMC ID: 18922847
Oppedal et al. 1987. Histopathology. 11(4):363-74. PMID: 3596475.
Immunohistochemical differentiation of neuroblastomas from other small round cell neoplasms of childhood using a panel of mono- and polyclonal antibodies.
Europe PMC ID: 3596475
Add a reference
References: 6 entries
Doldo et al. 2015. Genes Cancer. 6(11-12):490-502. PMID: 26807202.
IHC
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis.
Dubicke et al. 2008. Mol Hum Reprod. 14(11):641-7. PMID: 18922847.
IF
Different secretion patterns of matrix metalloproteinases and IL-8 and effect of corticotropin-releasing hormone in preterm and term cervical fibroblasts.
Oppedal et al. 1987. Histopathology. 11(4):363-74. PMID: 3596475.
Immunohistochemical differentiation of neuroblastomas from other small round cell neoplasms of childhood using a panel of mono- and polyclonal antibodies.
Add a reference
